For anyone living with food allergies—or caring for someone who does—the thought of experiencing a reaction at 30,000 feet can understandably trigger serious worry. People are well aware that help is far from being immediately available in the air, and

Anaphylm is a medicine being developed by Aquestive Therapeutics for the emergency treatment of serious allergic reactions, including anaphylaxis.

Researchers at the University of Southampton are inviting parents and caregivers of young infants to take part in a research study to help prevent food allergy in babies. This research is part of a doctorate project led by Karen Wright,

A new study using data from the European Anaphylaxis Registry has identified important changes in which tree nuts are most likely to cause serious allergic reactions (anaphylaxis) in children and adults across Europe. The results show that cashew nuts are

A new study, led by King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, has shown promising results, demonstrating that peanut oral immunotherapy (OIT) may be an effective treatment for adults with peanut allergies. The trial, known as

Researchers at the University of Bristol and the James Lind Alliance invite you to take part in the second phase of a UK-wide survey to prioritise the most urgent unanswered questions about childhood food allergy. This is the second part of the

A recent study led by researchers at the Icahn School of Medicine at Mount Sinai, New York, has provided encouraging evidence that a supervised, gradual peanut ingestion protocol may help children with a high-threshold peanut allergy increase their tolerance to

The University of Manchester is inviting individuals to participate in an event where they can share their healthcare experiences and contribute to meaningful discussions with student researchers. This research opportunity aims to help students learn directly from patients about their

The National Institute for Health and Care Excellence (NICE) has released its final draft guidance, recommending Acarizax for NHS use in the management of house dust mite allergy. Developed by ALK-Abello, Acarizax is the first therapy specifically designed to treat